The future of clinical research depends on people just as much as strong systems and processes. Learn what makes great ...

Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...

In 2026, clinical trial teams market uncertainty and identify high-impact areas for AI adoption to remain competitive.

Identifying copyright holders and response times are major challenges in COA licensing, causing delays in clinical trials. Clear documentation of copyright ownership and standardized response times ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...

Estonia is a hotbed of healthcare technology innovation, harnessing artificial intelligence (AI) and genomics. Its healthtech industry is targeting the UK and Europe for collaboration and market ...

Beena Wood, Qinecsa, saw 2025 as an AI superposition in which pharmacovigilence needed better data foundations and regulation ...

MITOLINE™ Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory ...

After a short delay and concerns of potential intervention from senior officials, the FDA has issued a draft guidance for the industry on the potential use of minimal residual disease (MRD) and ...

On Tuesday, November 18, the consortium of the European project MILenARI (Mediterranean International Lentivirus ARI) held ...

“Integrating these data in large samples allowed us to identify early metabolic pathway changes that precede type 2 diabetes, providing new insights into disease mechanisms,” said Jun Li, MD, ...